The Clinical and Economic Implications of Different Treatment Pathways for Patients With Rapidly Recurrent Malignant Pleural Effusion.

MLA

Ost, David E., et al. “The Clinical and Economic Implications of Different Treatment Pathways for Patients With Rapidly Recurrent Malignant Pleural Effusion.” CHEST, vol. 166, no. 4, Oct. 2024, pp. 867–81. EBSCOhost, https://doi.org/10.1016/j.chest.2024.04.036.

APA

Ost, D. E., Goldblatt, C., Jung, M., Weiss, M., Xu, S., Taneja, A., & Erdal, E. (2024). The Clinical and Economic Implications of Different Treatment Pathways for Patients With Rapidly Recurrent Malignant Pleural Effusion. CHEST, 166(4), 867–881. https://doi.org/10.1016/j.chest.2024.04.036

Chicago

Ost, David E., Claudia Goldblatt, Molly Jung, Mia Weiss, Shibei Xu, Ashley Taneja, and Erik Erdal. 2024. “The Clinical and Economic Implications of Different Treatment Pathways for Patients With Rapidly Recurrent Malignant Pleural Effusion.” CHEST 166 (4): 867–81. doi:10.1016/j.chest.2024.04.036.